会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 126. 发明申请
    • ENGINEERING PROJECT EVENT-DRIVEN SOCIAL NETWORKED COLLABORATION
    • 工程项目事件驱动社会网络合作
    • US20120198414A1
    • 2012-08-02
    • US13017010
    • 2011-01-30
    • Xiaozheng ChenMin Li(Jason) Jingcun WangLamar Damata
    • Xiaozheng ChenMin Li(Jason) Jingcun WangLamar Damata
    • G06F3/01G06F9/44
    • G06Q50/01G06Q10/101
    • Engineering team activities are facilitated through social networked collaboration driven by engineering project events. An engineering team member profile on a private network contains an identification of the team member including an offline name, direct links to profiles of other team members, automatically generated news items of team member engineering activities, and a summarized view of engineering project data. A news generator automatically collects engineering events and includes corresponding event descriptions in the profile, for wiki article updates, software bug reports, software modifications, project schedule changes, and other engineering events. Some news items automatically include a suggested engineering activity as a follow up for the team member to perform. For example, the team member may click a news item link to view an updated product specification, create a product test, view detailed test results, or create a virtual machine session.
    • 通过由工程项目活动推动的社交网络协作,促进了工程团队的活动。 私人网络上的工程团队成员简介包含团队成员的身份,包括离线名称,直接链接到其他团队成员的个人资料,自动生成团队成员工程活动的新闻项目,以及工程项目数据的概述。 新闻发生器自动收集工程事件,并在配置文件中包含相应的事件描述,用于wiki文章更新,软件错误报告,软件修改,项目进度更改和其他工程事件。 一些新闻项目会自动包括建议的工程活动,作为团队成员执行的跟进。 例如,团队成员可以单击新闻项目链接以查看更新的产品规格,创建产品测试,查看详细测试结果或创建虚拟机会话。
    • 129. 发明申请
    • Treatment of renal dysfunction and multiple myeloma using pacap compounds
    • 使用pacap化合物治疗肾功能障碍和多发性骨髓瘤
    • US20110288015A1
    • 2011-11-24
    • US11632734
    • 2005-07-21
    • Akira ArimuraMin Li
    • Akira ArimuraMin Li
    • A61K38/16A61P3/10A61P9/12A61P13/12A61P35/00
    • C07K14/57563A61K38/00
    • The present invention relates to methods and compositions for the treatment, management, or prevention of multiple myeloma and/or renal dysfunction in mammals. The methods of the invention comprise the administration of an effective amount of one or more pituitary adenylate cyclase activating polypeptide (“PACAP”) compounds, which includes PACAP, vasoactive intestinal peptide (“VIP”), their agonists, analogs, fragments, or derivatives, having one or more PACAP activities. The invention also provides pharmaceutical compositions comprising one or more PACAP compounds of the invention either alone or in combination with one or more other prophylactic/therapeutic agents useful in therapy for the treatment, management, or prevention of multiple myeloma and/or renal dysfunction.
    • 本发明涉及用于治疗,管理或预防哺乳动物多发性骨髓瘤和/或肾功能障碍的方法和组合物。 本发明的方法包括施用有效量的一种或多种垂体腺苷酸环化酶活化多肽(“PACAP”)化合物,其包括PACAP,血管活性肠肽(“VIP”),其激动剂,类似物,片段或衍生物 ,具有一个或多个PACAP活动。 本发明还提供包含本发明的一种或多种PACAP化合物的药物组合物,其单独或与一种或多种其它用于治疗,治疗或预防多发性骨髓瘤和/或肾功能障碍的预防/治疗剂组合。